Erythroleukemia: Classification
- PMID: 37206278
- PMCID: PMC10188454
- DOI: 10.1002/jha2.676
Erythroleukemia: Classification
Abstract
Acute erythroid leukemia (AEL) is a rare (2%-5%) form of acute myeloid leukemia (AML). Molecular alterations found in AEL resemble those of other AMLs. We report a classification of AELs in three major classes, with different prognosis and some specific features such as a tendency to mutual exclusion of mutations in epigenetic regulators and signaling genes.
Keywords: TP53; acute erythroid leukemia; molecular classification; mutations.
© 2023 The Authors. eJHaem published by British Society for Haematology and John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
References
-
- Jaffe ES, Harris NL, Stein H, Vardiman J. World Health Organization classification of tumours pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001.
-
- Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–405. - PubMed
-
- Grossmann V, Bacher U, Haferlach C, Schnittger S, Pötzinger F, Weissmann S, et al. Acute erythroid leukemia (AEL) can be separated into distinct prognostic subsets based on cytogenetic and molecular genetic characteristics. Leukemia. 2013;27(9):1940–3. - PubMed
-
- Cervera N, Carbuccia N, Garnier S, Guille A , Adélaïde J, Murati A, et al. Molecular characterization of acute erythroid leukemia (M6‐AML) using targeted next‐generation sequencing. Leukemia. 2016. 30(4):966–70. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous